Mineralys Therapeutics, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
MLYS on Nasdaq
Location
150 N. Radnor Chester Road, Suite F200, Radnor, Pennsylvania

Insiders trading volume in the past year

Mineralys Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Brian Taylor Slingsby Director, 10%+ Owner $113M -$7.18M -5.98% Jul 24, 2024
Samsara BioCapital GP, LLC 10%+ Owner $68.5M +$7.5M +12.3% Feb 12, 2024
Srinivas Akkaraju Director, 10%+ Owner $68.5M May 22, 2024
Ra Capital Management, L.P. Director $47.7M May 22, 2024
HBM Healthcare Investments (Cayman) Ltd. 10%+ Owner $19.2M Feb 14, 2023
Jon Congleton Chief Executive Officer, Director $12.2M -$1.7M -12.3% Jul 11, 2024
Adam Levy CFO and Secretary $3.25M -$1.39M -30% Jul 11, 2024
David Malcom Rodman Chief Medical Officer $1.49M -$9.38K -0.62% Aug 12, 2024
Daphne Karydas Director May 22, 2024
Derek DiRocco Director May 22, 2024
Alexander Asam Director Feb 9, 2023
Glenn Sblendorio Director May 22, 2024
Alexander M. Gold Director Jun 13, 2024
Olivier Litzka Director May 22, 2024
Takeshi Takahashi Director Jul 12, 2023

Recent Insider Transactions by Companies or Individuals for Mineralys Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.